Skip to content
StockMarketAgent
Consumer Discretionary / Personal ServicesUpdated 2026-05-10 22:07 UTC

MED stock hub

Medifast, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

MEDis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
129.1M
NYSE
Market data

Live price

Current market quote for this ticker.

Current price
MED
In the news

Latest news · MED

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11.5P50 15.8P75 23.1
Trailing P/En/a
P25 13.1P50 20.6P75 33.1
ROE-9.8
P25 -21.1P50 4.5P75 16.1
ROIC-42.3
P25 -4.5P50 5.2P75 12.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All MED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
224
Groups with data
11
Currency
USD
Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0000910329
Company name
Medifast, Inc.
Country
United States
Country code
US
Cusip
58470H101
Employees
380
Employees Change
-124%
Employees Change Percent
-24.6
Enterprise value
$-23.8M
Exchange
NYSE
Financial currency
USD
First seen
2026-05-09
Industry
Personal Services
Isin
US58470H1014
Last refreshed
2026-05-10
Market cap
$129.1M
Market cap category
Micro-Cap
Price
$12.59
Price currency
USD
Rev Per Employee
910,800x
Sector
Consumer Discretionary
Sic
2090
Symbol
MED
Website
https://medifastinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-15.51%
FCF yield
-1.14%
P/B ratio
0.65x
P/S ratio
0.37x
PE Ratio10 Y
37.22x
PE Ratio3 Y
84.35x
PE Ratio5 Y
50.57x
PS Forward
0.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
-5.32%
EBITDA Margin
-1.15%
Gross margin
70.12%
Gross Profit
$242.7M
Gross Profit Growth
-39.56%
Gross Profit Growth Q
-38.56%
Gross Profit Growth3 Y
-39.51%
Gross Profit Growth5 Y
-21.44%
Net Income
$-20M
Net Income Growth Years
0%
Pretax Margin
-2.34%
Profit Margin
-5.78%
Profit Per Employee
$-52,689
ROA
-4.33
Roa5y
19.51
ROCE
-8.78
ROE
-9.8
Roe5y
43.83
ROIC
-42.28
Roic5y
101.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr10y
-6.98%
Cagr15y
-1.27%
Cagr1y
-2.78%
Cagr20y
1.45%
Cagr3y
-47.58%
Cagr5y
-44.84%
Div CAGR3
0.05%
Div CAGR5
5.26%
EPS Growth Years
0
OCF Growth
-81.96%
OCF Growth Q
-92.37%
OCF Growth10 Y
-17.98%
OCF Growth3 Y
-74.14%
OCF Growth5 Y
-54.17%
Revenue Growth
-36.31x
Revenue Growth Q
-34.29x
Revenue Growth Years
0x
Revenue Growth3 Y
-39.07x
Revenue Growth5 Y
-20.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$1.3
Assets
$252M
Cash
$168.9M
Current Assets
$202.6M
Current Liabilities
$42.2M
Debt
$16.1M
Debt EBITDA
$15.86
Debt Equity
$0.08
Equity
$197.7M
Liabilities
$54.4M
Long Term Assets
$49.4M
Long Term Liabilities
$12.2M
Net Cash
$152.8M
Net Cash By Market Cap
$118
Net Cash Growth
1.91%
Net Debt Equity
$-0.77
Tangible Book Value
$197.7M
Tangible Book Value Per Share
$19.28
WACC
6.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.8
Inventory Turnover
3.4
Net Working Capital
$-4.6M
Quick ratio
4
Working Capital
$160.4M
Working Capital Turnover
$2.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

4
MetricValue
Buyback Yield
-0.51%
Dividend per share
$0
Dividend Yield
0%
Last Dividend
$1.65

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-51.48%
1Y total return
-2.78%
200-day SMA
11.92
3Y total return
-85.6%
50-day SMA
10.61
50-day SMA vs 200-day SMA
50under200
5Y total return
-94.89%
All Time High
337
All Time High Change
-96.26%
All Time High Date
2021-05-28
All Time Low
0.09
All Time Low Change
13,322.17%
All Time Low Date
1999-12-23
ATR
0.54
Beta
0.57
Beta1y
1.08
Beta2y
0.6
Ch YTD
17.88
High
12.81
High52
15.46
High52 Date
2025-07-10
High52ch
-18.56%
Low
12.43
Low52
9.22
Low52 Date
2026-03-13
Low52ch
36.55%
Ma50ch
18.71%
Price vs 200-day SMA
5.59%
RSI
69.65
RSI Monthly
29.55
RSI Weekly
58.23
Sharpe ratio
0.06x
Sortino ratio
0.24
Total Return
-0.51%
Tr YTD
17.88
Tr15y
-17.46%
Tr1m
23.43%
Tr1w
15.4%
Tr3m
10.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

9
MetricValue
Analyst Count
1
Analyst Ratings
Hold
Earnings EPS Estimate
$-0.53
Earnings Revenue Estimate
70,110,000x
Earnings Revenue Estimate Growth
-39.42x
Operating Income
$-18.4M
Operating margin
-5.32
Price target
$12
Price Target Change
$-4.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
8,456,812%
Float Percent
82.48%
Shares Insiders
3.49%
Shares Institutions
68.52%
Shares Out
10,253,115
Shares Qo Q
0.14%
Shares Yo Y
0.51%
Short Float
25.59%
Short Ratio
8.22
Short Shares
21.11

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

66
MetricValue
Adjusted FCF
$-9.1M
Average Volume
223,491.4x
Bv Per Share
19.28
CAPEX
$-5.2M
Ch10y
-62.64
Ch15y
-37.52
Ch1m
23.43
Ch1w
15.4
Ch1y
-2.78
Ch20y
1.04
Ch3m
10.83
Ch3y
-86.16
Ch5y
-95.48
Ch6m
5.53
Change
-0.79%
Change From Open
-0.63
Close
12.69
Days Gap
-0.16
Depreciation Amortization
14,445,000
Dollar Volume
1,412,421.7
Earnings Date
2026-05-04
Earnings Time
amc
EBIT
$-18.4M
EBITDA
$-4M
EPS
$-1.82
F Score
3
FCF
$-1.5M
FCF EV Yield
6.19x
FCF Per Share
$-0.14
Financing CF
-902,000
Fiscal Year End
December
Founded
1,980
Income Tax
$11.9M
Investing CF
-23,007,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-04
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-02-17
Ma150
11.29
Ma150ch
11.54%
Ma20
11.26
Ma20ch
11.85%
Net CF
-20,188,000
Next Earnings Date
2026-08-03
Open
12.67
Optionable
Yes
P OCF Ratio
34.73
Position In Range
42.11
Post Close
12.59
Postmarket Change Percent
-0.2
Postmarket Price
$12.57
Ppne
42,564,000
Price Date
2026-05-08
Ptbv Ratio
0.65
Relative Volume
0.5x
Revenue
346,104,000x
SBC By Revenue
2.2x
Share Based Comp
7,605,000
Tax By Revenue
3.44x
Tr20y
33.48%
Tr6m
5.53%
Us State
Maryland
Volume
112,186
Z Score
4.19
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does MED pay a dividend?

Capital-return profile for this ticker.

Performance

MED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-2.8%
S&P 500 1Y: n/a
3Y total return
-85.6%
S&P 500 3Y: n/a
5Y total return
-94.9%
S&P 500 5Y: n/a
10Y total return
-51.5%
S&P 500 10Y: n/a
Ownership

Who owns MED?

Insider, institutional, and short-interest positioning.

Institutional ownership
+68.5%
Float: +82.5% of shares outstanding
Insider ownership
+3.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+25.6%
8.2 days to cover
Y/Y dilution
+0.5%
Negative means the company is buying back shares.
Technical

MED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
69.6
Neutral momentum band
Price vs 200-day MA
+5.6%
50/200-day relationship not available
Beta (5Y)
0.57
Less volatile than the market
Sharpe ratio
0.06
Risk-adjusted return — higher is better; >1.0 is solid.
Peers

MED vs. sector cohort

Currency-neutral comparison: P/E, P/S, ROIC, 5Y revenue CAGR, and 1Y total return. Market-cap column appears only when every peer reports in the same currency.

TickerNameMarket capP/EP/SROIC5Y rev CAGR1Y total returnRating
ABNBAirbnb Inc.84B34.7x6.6x15.9%+29.9%+14.9%보유
AMZNAmazon.com Inc.2.9T32.6x3.9x13.5%+12.1%+44.5%비중 축소
BKNGBooking Holdings Inc.128.6B21.8x4.6x57.9%+37.4%-19.6%매수
Questions

About MED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MED stock rating?

Medifast, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MED analysis?

The full report lives at /stocks/MED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MED?

The latest report frames MED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.